Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 430
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Exp Cell Res ; 396(2): 112324, 2020 11 15.
Article in English | MEDLINE | ID: mdl-33065114

ABSTRACT

In previous work, we showed that highly proliferative cells and cancer cells, but not cells with normal growth rate, have tubules rich in alpha-1,2 fucosylated epitopes that extend radially from the nucleus to the cell periphery and form an unusual uptake system. The importance of alpha-1,2 fucosylation in forming tubules was demonstrated by proving that down-regulating the two corresponding fucosyltransferases (FUT1 and FUT2) causes tubule fragmentation. Here, we present evidence that in the prostate cancer cell line DU145, the tubules arise in actively growing cells from vesicles in the medial and trans elements of a partially fragmented Golgi complex, while in not actively growing cells the tubules become completely independent from the Golgi complex. Formation and elongation of the tubules proved to depend on the actin cytoskeleton, since the alpha-1,2 fucosylated protein(s) segregate with the cytoskeleton proteins, and not in the membrane fraction, as do the Golgi markers and other fucosylated proteins, while depolymerization of the actin filaments causes tubule fragmentation and shifting of the alpha-1,2 fucosylated proteins into the membrane fraction.


Subject(s)
Actins/metabolism , Fucose/metabolism , Golgi Apparatus/metabolism , Prostatic Neoplasms/metabolism , Actin Cytoskeleton/drug effects , Actin Cytoskeleton/metabolism , Cell Line, Tumor , Cytochalasins/pharmacology , Epitopes/metabolism , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/pathology , Glycosylation/drug effects , Golgi Apparatus/drug effects , Golgi Apparatus/ultrastructure , Humans , Lectins/metabolism , Male , Prostatic Neoplasms/pathology , Prostatic Neoplasms/ultrastructure
2.
Ann Diagn Pathol ; 50: 151678, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33341702

ABSTRACT

Studies have shown that Gleason grade 4 extent as well as architectural subtypes provide prognostic information. We aimed to evaluate the influence on biochemical recurrence following radical prostatectomy of patients with organ-confined tumor, Gleason score 7, and negative surgical margins. Total tumor extent, Gleason grade 4 total extent and the extent of each architectural subtype (fused glands, poorly defined glands, cribriform glands, and glomeruloid glands) were evaluated by a semiquantitative point-count method using different colors to identify each subtype. Microscopic morphology of glomeruloid glands was considered regardless of morphology: size (small or large), attachment (narrow or extensive), and cribriform or solid intraluminal protrusion. Gleason grade 4 total extent significantly predicted shorter time to biochemical recurrence in univariate and multivariate analysis. Stratifying extent, Gleason grade 4 with >30% of the total grade 4 extent was significantly predictive for time of recurrence. Considering architectural subtypes, cribriform and glomeruloid glands but not fused and poorly formed glands extent, significantly predicted shorter time to recurrence in univariate analysis. An important issue related to the studies on prognostic significance of Gleason grade 4 subtypes is the lack of uniformity in the definition of microscopic morphology of the subtypes particularly of the glomeruloid architecture.


Subject(s)
Biomarkers, Tumor/analysis , Neoplasm Grading/methods , Prostatectomy/methods , Prostatic Neoplasms/pathology , Prostatic Neoplasms/surgery , Adult , Humans , Male , Margins of Excision , Middle Aged , Neoplasm Recurrence, Local/pathology , Predictive Value of Tests , Prognosis , Prostate-Specific Antigen/blood , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/ultrastructure , Retrospective Studies
3.
Sensors (Basel) ; 19(1)2019 Jan 03.
Article in English | MEDLINE | ID: mdl-30609788

ABSTRACT

Although prostate cancer is one of the most common cancers in the male population, its basic biological function at a cellular level remains to be fully understood. This lack of in depth understanding of its physiology significantly hinders the development of new, targeted and more effective treatment strategies. Whilst electrophysiological studies can provide in depth analysis, the possibility of recording electrical activity in large populations of non-neuronal cells remains a significant challenge, even harder to address in the picoAmpere-range, which is typical of cellular level electrical activities. In this paper, we present the measurement and characterization of electrical activity of populations of prostate cancer cells PC-3, demonstrating for the first time a meaningful electrical pattern. The low noise system used comprises a multi-electrode array (MEA) with circular gold electrodes on silicon oxide substrates. The extracellular capacitive currents present two standard patterns: an asynchronous sporadic pattern and a synchronous quasi-periodic biphasic spike pattern. An amplitude of ±150 pA, a width between 50⁻300 ms and an inter-spike interval around 0.5 Hz characterize the quasi-periodic spikes. Our experiments using treatment of cells with Gd³âº, known as an inhibitor for the Ca²âº exchanges, suggest that the quasi-periodic signals originate from Ca²âº channels. After adding the Gd³âº to a population of living PC-3 cells, their electrical activity considerably decreased; once the culture was washed, thus eliminating the Gd³âº containing medium and addition of fresh cellular growth medium, the PC-3 cells recovered their normal electrical activity. Cellular viability plots have been carried out, demonstrating that the PC-3 cells remain viable after the use of Gd³âº, on the timescale of this experiment. Hence, this experimental work suggests that Ca²âº is significantly affecting the electrophysiological communication pattern among PC-3 cell populations. Our measuring platform opens up new avenues for real time and highly sensitive investigations of prostate cancer signalling pathways.


Subject(s)
Electrophysiological Phenomena , Extracellular Space/physiology , Prostatic Neoplasms/ultrastructure , Calcium Channel Blockers/pharmacology , Electricity , Electrodes , Electrophysiological Phenomena/drug effects , Gadolinium/pharmacology , Humans , Ion Channel Gating/drug effects , Male , Models, Biological , PC-3 Cells , Prostatic Neoplasms/metabolism
4.
J Cell Biochem ; 119(9): 7127-7142, 2018 09.
Article in English | MEDLINE | ID: mdl-29923622

ABSTRACT

Nuclear alterations are a hallmark of many types of cancers, including prostate cancer (PCa). Recent evidence shows that subvisual changes, ones that may not be visually perceptible to a pathologist, to the nucleus and its ultrastructural components can precede visual histopathological recognition of cancer. Alterations to nuclear features, such as nuclear size and shape, texture, and spatial architecture, reflect the complex molecular-level changes that occur during oncogenesis. Quantitative nuclear morphometry, a field that uses computational approaches to identify and quantify malignancy-induced nuclear changes, can enable a detailed and objective analysis of the PCa cell nucleus. Recent advances in machine learning-based approaches can now automatically mine data related to these changes to aid in the diagnosis, decision making, and prediction of PCa prognoses. In this review, we use PCa as a case study to connect the molecular-level mechanisms that underlie these nuclear changes to the machine learning computational approaches, bridging the gap between the clinical and computational understanding of PCa. First, we will discuss recent developments to our understanding of the molecular events that drive nuclear alterations in the context of PCa: the role of the nuclear matrix and lamina in size and shape changes, the role of 3-dimensional chromatin organization and epigenetic modifications in textural changes, and the role of the tumor microenvironment in altering nuclear spatial topology. We will then discuss the advances in the applications of machine learning algorithms to automatically segment nuclei in prostate histopathological images, extract nuclear features to aid in diagnostic decision making, and predict potential outcomes, such as biochemical recurrence and survival. Finally, we will discuss the challenges and opportunities associated with translation of the quantitative nuclear morphometry methodology into the clinical space. Ultimately, accurate identification and quantification of nuclear alterations can contribute to the field of nucleomics and has applications for computationally driven precision oncologic patient care.


Subject(s)
Chromatin/pathology , Image Interpretation, Computer-Assisted/methods , Machine Learning , Prostatic Neoplasms/pathology , Cell Nucleus Shape , Cell Nucleus Size , Cell Transformation, Neoplastic/ultrastructure , Chromatin/ultrastructure , Epigenesis, Genetic , Genomic Instability , Humans , Male , Prognosis , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/ultrastructure , Tumor Microenvironment
5.
Br J Cancer ; 117(5): 752-755, 2017 Aug 22.
Article in English | MEDLINE | ID: mdl-28742796

ABSTRACT

BACKGROUND: Leukocyte telomere length (LTL) is a potential biomarker of cancer prognosis; however, evidence for renal cell carcinoma (RCC) is inconsistent. METHODS: We investigated LTL and RCC-specific survival among 684 cases from the US kidney cancer study (USKC) and 241 cases from the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO). Leukocyte telomere length was measured by quantitative polymerase chain reaction, and hazard ratios (HRs) and 95% confidence intervals (CIs) computed using multivariable Cox models. RESULTS: Short LTL was associated with poorer disease-specific survival in both USKC (lowest vs highest quartile: HR: 2.3, 95% CI: 1.2-4.4; P for trend=0.02) and PLCO (HR: 2.4, 95% CI: 1.0-5.4; P=0.04). Among USKC cases, the association was strongest for stage-I RCC (HR: 5.5, 95% CI: 1.6-19.0; P=0.006). CONCLUSIONS: Our findings suggest that shorter LTL is an independent marker of poor RCC prognosis, particularly for stage-I disease.


Subject(s)
Carcinoma, Renal Cell/ultrastructure , Colorectal Neoplasms/ultrastructure , Kidney Neoplasms/ultrastructure , Leukocytes/ultrastructure , Lung Neoplasms/ultrastructure , Ovarian Neoplasms/ultrastructure , Prostatic Neoplasms/ultrastructure , Telomere Shortening , Telomere/ultrastructure , Aged , Biomarkers, Tumor/blood , Biomarkers, Tumor/genetics , Carcinoma, Renal Cell/blood , Carcinoma, Renal Cell/genetics , Carcinoma, Renal Cell/mortality , Case-Control Studies , Colorectal Neoplasms/blood , Colorectal Neoplasms/genetics , Colorectal Neoplasms/mortality , Female , Humans , Kidney Neoplasms/blood , Kidney Neoplasms/genetics , Kidney Neoplasms/mortality , Lung Neoplasms/blood , Lung Neoplasms/genetics , Lung Neoplasms/mortality , Male , Middle Aged , Ovarian Neoplasms/blood , Ovarian Neoplasms/genetics , Ovarian Neoplasms/mortality , Prognosis , Prostatic Neoplasms/blood , Prostatic Neoplasms/genetics , Prostatic Neoplasms/mortality , Survival Rate
6.
J Cell Biochem ; 117(4): 1027-32, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26515240

ABSTRACT

The cellular basis of metastasis is poorly understood. An important step to understanding this process is to be able to visualize the routes by which cancer cells migrate from the primary tumor to various distant sites to eventually form metastasis. Our laboratory previously developed single-cell in vivo imaging using fluorescent proteins to label cancer cells. In the present study, using PC-3 human prostate cancer cells labeled with green fluorescent protein (GFP) and orthotopic tumor transplantation, we have imaged in live mice various highly diverse routes by which PC-3 cells metastasize superiorly and inferiorly to distant sites, including in the portal area, stomach area, and urogenital system. Imaging began at day 9, at which time distant metastasis had already occurred, and increased at each imaging point at days 10, 13, 14, and 16. Metastatic cells were observed migrating superiorly and inferiorly from the primary tumor as well as in lymphatic channels and trafficking in various organ systems demonstrating that PC-3 has multiple metastatic routes similar to hormone-independent advanced-stage prostate cancer in the clinic.


Subject(s)
Cell Tracking/methods , Diagnostic Imaging/methods , Pancreatic Neoplasms/diagnosis , Prostatic Neoplasms/diagnosis , Stomach Neoplasms/diagnosis , Testicular Neoplasms/diagnosis , Urinary Bladder Neoplasms/diagnosis , Animals , Cell Line, Tumor , Cell Movement , Gene Expression , Genes, Reporter , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Lymphatic Metastasis , Male , Mice , Mice, Nude , Mice, Transgenic , Neoplasm Invasiveness , Neoplasm Transplantation , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/secondary , Pancreatic Neoplasms/ultrastructure , Prostate/metabolism , Prostate/pathology , Prostate/ultrastructure , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Prostatic Neoplasms/ultrastructure , Stomach Neoplasms/genetics , Stomach Neoplasms/secondary , Stomach Neoplasms/ultrastructure , Testicular Neoplasms/genetics , Testicular Neoplasms/secondary , Testicular Neoplasms/ultrastructure , Transplantation, Heterologous , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/secondary , Urinary Bladder Neoplasms/ultrastructure
7.
Prostate ; 76(4): 409-24, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26643154

ABSTRACT

BACKGROUND: Remodeling of the tumor environment and the modulation of tumor associated non-malignant cells are essential events in tumor progression. Exosomes are small membranous vesicles of 50-150 nm in diameter, which are secreted into the extracellular space and supposedly serve as vehicles for signal and effector molecules to modulate adjacent target cells. We characterized the mRNA and protein composition as well as cellular functions of prostate cancer cell-derived exosomes. METHODS: Exosomes were prepared from prostate cancer cell culture supernatant by ultracentrifugation and subsequently characterized by dynamic light scattering and electron microscopy. Exosomal mRNA and protein composition were analyzed by DNA microarrays and gel electrophoresis coupled with mass spectrometry. Physiological effects of exosomes were studied by means of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and lactate dehydrogenase release cell assays. Using a SILAC approach, putative uptake of exosomal human proteins in canine cells and canine de novo synthesis of proteins specified by exosome-transferred human mRNA was analyzed in MDCK cells via mass spectrometry. RESULTS: Preparations of exosomes revealed typical cup shaped particles of 150 nm in diameter. Analysis of mRNA and protein composition of exosomes exhibited a wide range of mRNA and protein species. Interestingly, the packaging of at least small proteins into exosomes was apparently unspecific, as shown with the example of two model proteins. In cell culture incubation experiments exosomal preparations of prostate cancer cells caused anti-proliferative effects. MS analysis revealed the uptake of exosomal human proteins into canine cells after 6 hr of incubation. CONCLUSIONS: The results reveal a distinct exosomal functionality in the modulation of the prostatic tumor adjacent environment. The multitude of translocated factors implies the induction of numerous effects in tumor-associated target cells, including impact on cellular growth.


Subject(s)
Exosomes/physiology , Prostatic Neoplasms/ultrastructure , Proteins/metabolism , RNA, Messenger/metabolism , Animals , Cell Communication/physiology , Cell Line, Tumor , Dogs , Dynamic Light Scattering , Exosomes/ultrastructure , HEK293 Cells , Humans , Madin Darby Canine Kidney Cells , Male , Microscopy, Electron, Transmission , Particle Size , Protein Transport/physiology , Proteins/analysis , RNA Transport/physiology , RNA, Messenger/analysis , Tumor Microenvironment
8.
Br J Cancer ; 114(11): 1243-50, 2016 May 24.
Article in English | MEDLINE | ID: mdl-27124335

ABSTRACT

BACKGROUND: Pathological evaluations give the best prognostic markers for prostate cancer patients after radical prostatectomy, but the observer variance is substantial. These risk assessments should be supported and supplemented by objective methods for identifying patients at increased risk of recurrence. Markers of epigenetic aberrations have shown promising results in several cancer types and can be assessed by automatic analysis of chromatin organisation in tumour cell nuclei. METHODS: A consecutive series of 317 prostate cancer patients treated with radical prostatectomy at a national hospital between 1987 and 2005 were followed for a median of 10 years (interquartile range, 7-14). On average three tumour block samples from each patient were included to account for tumour heterogeneity. We developed a novel marker, termed Nucleotyping, based on automatic assessment of disordered chromatin organisation, and validated its ability to predict recurrence after radical prostatectomy. RESULTS: Nucleotyping predicted recurrence with a hazard ratio (HR) of 3.3 (95% confidence interval (CI), 2.1-5.1). With adjustment for clinical and pathological characteristics, the HR was 2.5 (95% CI, 1.5-4.1). An updated stratification into three risk groups significantly improved the concordance with patient outcome compared with a state-of-the-art risk-stratification tool (P<0.001). The prognostic impact was most evident for the patients who were high-risk by clinical and pathological characteristics and for patients with Gleason score 7. CONCLUSION: A novel assessment of epigenetic aberrations was capable of improving risk stratification after radical prostatectomy.


Subject(s)
Adenocarcinoma/ultrastructure , Chromatin/ultrastructure , Neoplasm Recurrence, Local/epidemiology , Prostatectomy , Prostatic Neoplasms/ultrastructure , Adenocarcinoma/genetics , Adenocarcinoma/surgery , Aged , Aneuploidy , Cell Nucleus/ultrastructure , Epigenesis, Genetic , Follow-Up Studies , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasm Recurrence, Local/genetics , Prognosis , Prostatic Neoplasms/genetics , Prostatic Neoplasms/surgery , Risk Assessment , Severity of Illness Index , Treatment Failure
9.
Ultrastruct Pathol ; 40(4): 189-99, 2016.
Article in English | MEDLINE | ID: mdl-27044781

ABSTRACT

The intracellular or intracytoplasmic lumen (IL) is an enigmatic histological structure that occurs in various tumor cells. A reassessment of diverse ILs fine-structure micrographs obtained out of previous studies encompassing the human prostate carcinoma (DU145) cell line and xenotransplanted carcinomas enabled us to propose aspects of ILs development in cancer cells: a combination of altered expressions in intercellular contacts and their cytoskeletal components would favor a disarray of self-apical polarity orientation; those defects, associated with a local, entwined enriched membranous structures growing as microvilli-like formations out of a disrupted endoplasm and trans-Golgi sorting, create ILs in cells' perikarya. These misplaced intracytoplasmic domains can become enlarged through spaces made between the finger-like structures by accruing membranes of coalescent intracytoplasmic vesicles then adding microvilli and glycocalyx to constitute ILs. Cationic mucins added with or without a progressive or total loss of microvilli and content generate signet or ring cell, while ILs enlarge. Variable build-ups of these cells' populations in carcinomas result in architectural mix-up of adjacent cells around these voids, misconstrued as new lumen, and establish a "cribriform" tumor pattern that often implies a poor cancer prognosis. Alternatively, cytotoxic changes caused by anticancer pro-oxidant treatment favor membrane alterations and exaggerate the ILs in xenotransplants into intracellular crypts that accompany other tumor degenerative changes.


Subject(s)
Carcinoma/pathology , Carcinoma/ultrastructure , Prostatic Neoplasms/pathology , Prostatic Neoplasms/ultrastructure , Animals , Cell Differentiation , Cell Line, Tumor , Heterografts , Humans , Male , Mice , Mice, Nude , Microscopy, Electron, Transmission
10.
Prostate ; 75(10): 1063-73, 2015 Jul 01.
Article in English | MEDLINE | ID: mdl-25783430

ABSTRACT

BACKGROUND: Prostasomes are nanosized extracellular vesicles exocytosed by prostate epithelial cells. They have been assigned many roles propitious to sperm in favor of fertilization. Prostatic cancer cells can also produce and secrete extracellular vesicles. METHODS: We assessed using ELISA, the surface expression of chromogranin proproteins on prostasomes and malignant extracellular vesicles of four different prostate cancer cell-lines, two hormone sensitive and two hormone refractory. We used a panel of chromogranin A and chromogranin B antibodies against peptides in-between hypothetical cleavage sites along the proproteins. RESULTS: A diverging pattern of chromogranin peptides was apparent when comparing prostasomes and malignant extracellular vesicles indicating a phenotypical change. We also compared western blot patterns (prostasomes and malignant extracellular vesicles) for selected antibodies that displayed high absorbances in the ELISA. Western blot analyses revealed various cleavage patterns of those proproteins that were analyzed in prostasomes and extracellular vesicles. CONCLUSION: Chromogranins are constituents of not only prostasomes but also of malignant prostate cell-derived extracellular vesicles with different amino acid sequences exposed at the membrane surface giving rise to a mosaic pattern. These findings may be of relevance for designing new assays for detection or even possible treatment of prostate cancers.


Subject(s)
Chromogranins/analysis , Exosomes/chemistry , Extracellular Space , Prostatic Neoplasms/ultrastructure , Blotting, Western , Cell Line, Tumor , Chromogranins/chemistry , Enzyme-Linked Immunosorbent Assay , Epithelial Cells/chemistry , Epithelial Cells/ultrastructure , Exocytosis , Exosomes/ultrastructure , Humans , Male , Microscopy, Electron, Transmission , Semen
11.
Bioconjug Chem ; 26(4): 782-9, 2015 Apr 15.
Article in English | MEDLINE | ID: mdl-25760776

ABSTRACT

We report a click-chemistry based modular strategy for antibody labeling with (64)Cu (t1/2 = 12.7 h; ß(+) 0.656 MeV, 17.4%; ß(-) 0.573 MeV, 39%; EC 43%) under ambient condition utilizing a cross-bridged tetraazamacrocyclic (CB-TE2A) analogue, which otherwise requires harsh conditions that make the CB-TE2A analogues under-utilized for protein labeling despite the fact that they form kinetically inert copper complexes with high in vivo stability. Our strategy involves prelabeling a CB-TE2A based scaffold (CB-TE2A-1C) with (64)Cu and its subsequent reaction with an antibody via the tetrazine-norbornene mediated click chemistry. The effectiveness of this strategy was demonstrated by labeling two monoclonal antibodies, an anti-PSMA antibody (YPSMA-1) and a chimeric anti-phosphatidylserine antibody (Bavituximab). The immunoreactivity of the antibodies remained unchanged after the tetrazine modification and click-chemistry (64)Cu labeling. To further demonstrate the practicality of the modular (64)Cu labeling strategy, we tested positron emission tomography (PET) imaging of tumor with the (64)Cu-labeled bavituximab in a mouse xenograft model. The tumor visualization and uptake of the labeled antibody exhibited the versatility of the click-chemistry strategy.


Subject(s)
Adenocarcinoma/diagnostic imaging , Antibodies, Monoclonal/chemistry , Chelating Agents/chemical synthesis , Copper Radioisotopes/chemistry , Heterocyclic Compounds, 1-Ring/chemical synthesis , Prostatic Neoplasms/diagnostic imaging , Radiopharmaceuticals/chemistry , Adenocarcinoma/genetics , Adenocarcinoma/ultrastructure , Animals , Antibodies, Monoclonal/pharmacokinetics , Antigens, Surface/genetics , Antigens, Surface/metabolism , Chelating Agents/chemistry , Click Chemistry , Gene Expression , Glutamate Carboxypeptidase II/antagonists & inhibitors , Glutamate Carboxypeptidase II/genetics , Glutamate Carboxypeptidase II/metabolism , Heterocyclic Compounds, 1-Ring/chemistry , Humans , Male , Mice , Positron-Emission Tomography , Prostatic Neoplasms/genetics , Prostatic Neoplasms/ultrastructure , Staining and Labeling/methods , Xenograft Model Antitumor Assays
12.
Expert Rev Proteomics ; 11(2): 167-77, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24564711

ABSTRACT

Exosomes and other microvesicles are emerging as rich reservoirs of tumor-specific proteins and biomarkers for cancer detection and progression. For prostate cancer, exosomes secreted by the prostate can be isolated from prostatic secretions, seminal fluid, tissue, urine or blood for further proteomic analysis. Structurally, prostate-derived exosomes are distinct in size, membrane composition and specific prostate protein content, potentially providing a novel and easily isolatable source of biomarkers from clinical biofluids. The key to these isolation strategies will be the targeting of specific prostatic proteins expressed in these exosomes, thus requiring detailed proteomic characterizations. A summary of ongoing efforts to characterize the proteome of these unique prostate cancer-associated exosomes and their potential applications for use in biomarker assays is presented.


Subject(s)
Biomarkers, Tumor/metabolism , Exosomes/metabolism , Prostatic Neoplasms/diagnosis , Proteome/metabolism , Exosomes/ultrastructure , Glycoproteins/metabolism , Humans , Male , Polysaccharides/metabolism , Prostate/metabolism , Prostate/pathology , Prostatic Neoplasms/metabolism , Prostatic Neoplasms/ultrastructure , Semen/metabolism
13.
J Magn Reson Imaging ; 39(6): 1443-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24243824

ABSTRACT

PURPOSE: To compare utility of T2-weighted (T2W) MRI and diffusion-weighted MRI (DWI-MRI) obtained with and without an endorectal coil at 3 Tesla (T) for localizing prostate cancer. MATERIALS AND METHODS: This Institutional Review Board-approved study included 20 patients (median prostate-specific antigen, 8.4 ng/mL). Patients underwent consecutive prostate MRIs at 3T, first with a surface coil alone, then with combination of surface, endorectal coils (dual coil) followed by robotic assisted radical prostatectomy. Lesions were mapped at time of acquisition on dual-coil T2W, DWI-MRI. To avoid bias, 6 months later nonendorectal coil T2W, DWI-MRI were mapped. Both MRI evaluations were performed by two readers blinded to pathology with differences resolved by consensus. A lesion-based correlation with whole-mount histopathology was performed. RESULTS: At histopathology 51 cancer foci were present ranging in size from 2 to 60 mm. The sensitivity of the endorectal dual-coil, nonendorectal coil MRIs were 0.76, 0.45, respectively. PPVs for endorectal dual-coil, nonendorectal coil MRI were 0.80, 0.64, respectively. Mean size of detected lesions with nonendorectal coil MRI were larger than those detected by dual-coil MRI (22 mm versus 17.4 mm). CONCLUSION: Dual-coil prostate MRI detected more cancer foci than nonendorectal coil MRI. While nonendorectal coil MRI is an attractive alternative, physicians performing prostate MRI should be aware of its limitations.


Subject(s)
Magnetic Resonance Imaging/instrumentation , Magnetic Resonance Imaging/methods , Prostate/pathology , Prostatic Neoplasms/diagnosis , Aged , Contrast Media , Diffusion Magnetic Resonance Imaging/instrumentation , Diffusion Magnetic Resonance Imaging/methods , Humans , Image Enhancement/methods , Imaging, Three-Dimensional/methods , Magnetics , Male , Middle Aged , Prospective Studies , Prostate/ultrastructure , Prostatic Neoplasms/ultrastructure , Reproducibility of Results , Sensitivity and Specificity
14.
Pathol Biol (Paris) ; 62(3): 129-36, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24745345

ABSTRACT

AIM: The relevance of prostate specific antigen (PSA)-prostate specific membrane antigen (PSMA) profiles in pathologic prostate (hyperplasia and cancer) has not been fully understood. The aim of this study is to investigate the impact of PSA-PSMA profiles on sera PSA levels and angiogenic activity in benign prostate hyperplasia (BPH) and prostate carcinoma (PC). PATIENTS AND METHODS: The study has been carried out in 6 normal prostate (NP), 29 BPH and 33 PC with dominant Gleason grade>8. Immunohistochemical analysis has been performed. Monoclonal antibodies 3E6 and ER-PR8 have been used to assess PSMA and PSA expression respectively. The evaluation of angiogenesis has been made by CD34 immune marker. Serum levels of PSA have been assayed by Immulite autoanalyser. RESULTS: The study of each protein separately among sera PSA levels showed that PSMA expression and angiogenic activity have the highest intensity in PC patients with serum PSA levels>20 ng/mL. Nevertheless, the lowest tissue PSA expression was found in PC patients with this latter sera PSA group. The most relevant results showed that in PC patients (PSA+, PSMA+) and (PSA-, PSMA+) profile were found to be inversely related to sera PSA levels. In PC patients, a high immunoexpression of (PSA+, PSMA+) profile has detected in the sera PSA group>20 ng/mL; whereas a high immunoexpression of (PSA-, PSMA+) profile was detected in the sera PSA group between 0 and 4 ng/mL. The highest angiogenic activity was found in PC patients with (PSA+, PSMA+) profile. CONCLUSIONS: Our findings clearly have supported the feasibility of PSA-PSMA profiles to improve in vivo diagnostic and therapeutic approaches in prostate cancer patients.


Subject(s)
Adenocarcinoma/chemistry , Antigens, Surface/analysis , Glutamate Carboxypeptidase II/analysis , Neovascularization, Pathologic/metabolism , Prostate-Specific Antigen/analysis , Prostate/chemistry , Prostatic Hyperplasia/metabolism , Prostatic Neoplasms/chemistry , Adenocarcinoma/blood , Adenocarcinoma/blood supply , Adenocarcinoma/enzymology , Adenocarcinoma/surgery , Adenocarcinoma/ultrastructure , Adult , Aged , Aged, 80 and over , Antigens, CD34/analysis , Cell Compartmentation , Cell Membrane/enzymology , Cytoplasm/chemistry , Epithelial Cells/chemistry , Epithelial Cells/enzymology , Epithelial Cells/ultrastructure , Feasibility Studies , Humans , Male , Middle Aged , Neovascularization, Pathologic/blood , Neovascularization, Pathologic/pathology , Prostate/enzymology , Prostate/ultrastructure , Prostate-Specific Antigen/blood , Prostatectomy , Prostatic Hyperplasia/blood , Prostatic Hyperplasia/pathology , Prostatic Hyperplasia/surgery , Prostatic Neoplasms/blood , Prostatic Neoplasms/blood supply , Prostatic Neoplasms/enzymology , Prostatic Neoplasms/surgery , Prostatic Neoplasms/ultrastructure , Transurethral Resection of Prostate , Young Adult
15.
Ultrastruct Pathol ; 38(2): 116-40, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24460713

ABSTRACT

Scanning (SEM) and transmission electron microscopy (TEM) were used to characterize the cytotoxic effects of ascorbate (VC), menadione (VK3), or a VC:VK3 combination on a human prostate carcinoma cell line (DU145) following a 1-h vitamin treatment and a subsequent 24-h incubation in culture medium. Cell alterations examined by light and electron microscopy were treatment-dependent with VC + VK3 >VK3 > VC > Sham. Oxidative stress-induced damage was found in most organelles. This report describes injuries in the tumor cell nucleus (chromatin and nucleolus), mitochondria, endomembranes, lysosomal bodies (autophagocytoses) and inclusions. Morphologic alterations suggest that cytoskeleton damage is likely responsible for the superficial cytoplasmic changes, including major changes in cell shape and size and the self-excising phenomena. Unlike apoptotic bodies, the excised pieces contain ribonucleoproteins, but not organelles. These deleterious events cause a progressive, significant reduction in the tumor cell size. During nuclear alterations, the nuclei maintain their envelope during chromatolysis and karyolysis until cell death, while nucleoli undergo a characteristic segregation of their components. In addition, changes in fat and glycogen storage are consistent the cytotoxic and metabolic alterations caused by the respective treatments. All cellular ultrastructural changes are consistent with cell death by autoschizis and not apoptosis or other kinds of cell death.


Subject(s)
Adenocarcinoma/ultrastructure , Ascorbic Acid/pharmacology , Cell Death/drug effects , Prostatic Neoplasms/ultrastructure , Vitamin K 3/pharmacology , Cell Line, Tumor , Cell Nucleus/drug effects , Cell Nucleus/ultrastructure , Cytoskeleton/drug effects , Cytoskeleton/ultrastructure , Humans , Male , Microscopy, Electron , Organelles/drug effects , Organelles/ultrastructure
16.
Am J Pathol ; 181(5): 1573-84, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23022210

ABSTRACT

Oncosomes are tumor-derived microvesicles that transmit signaling complexes between cell and tissue compartments. Herein, we show that amoeboid tumor cells export large (1- to 10-µm diameter) vesicles, derived from bulky cellular protrusions, that contain metalloproteinases, RNA, caveolin-1, and the GTPase ADP-ribosylation factor 6, and are biologically active toward tumor cells, endothelial cells, and fibroblasts. We describe methods by which large oncosomes can be selectively sorted by flow cytometry and analyzed independently of vesicles <1 µm. Structures resembling large oncosomes were identified in the circulation of different mouse models of prostate cancer, and their abundance correlated with tumor progression. Similar large vesicles were also identified in human tumor tissues, but they were not detected in the benign compartment. They were more abundant in metastases. Our results suggest that tumor microvesicles substantially larger than exosome-sized particles can be visualized and quantified in tissues and in the circulation, and isolated and characterized using clinically adaptable methods. These findings also suggest a mechanism by which migrating tumor cells condition the tumor microenvironment and distant sites, thereby potentiating advanced disease.


Subject(s)
Cell-Derived Microparticles/pathology , Prostatic Neoplasms/blood , Prostatic Neoplasms/pathology , ADP-Ribosylation Factor 6 , Animals , Caveolin 1/metabolism , Cell Line, Tumor , Cell-Derived Microparticles/ultrastructure , Flow Cytometry , Humans , Male , Mice , Models, Biological , Neoplasm Invasiveness , Neoplasm Metastasis , Prostatic Neoplasms/ultrastructure
17.
Ultrastruct Pathol ; 37(6): 440-8, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23957452

ABSTRACT

DU145 human prostate carcinoma cells are typically poorly differentiated and contain only scantily distributed organelles. However, among numerous tumor cells randomly examined by electron microscopy out of in vitro cultivation, a peculiar, rare oncocyte-like cell type has been observed whose nucleus appears to be of small dimension and with a cytoplasm almost entirely filled with often distorted mitochondria. A few small, dispersed lysosomal bodies, small cisterns of the endoplasmic reticulum and a few glycogen patches can be found among highly osmiophilic contrasted, cytosolic spaces filled by innumerable ribonucleoproteins. The excessive population of mitochondria may have arisen from a more populated tumor cell type wherein the altered mitochondria are found to appear burgeoning into a spherical-like size progeny crowding the tumor cells. Literature cited between 1950 and the present suggests that this rare, oncocytic, benign prostatic tumor cell type is likely appear epigenetically, stemming from an original secretory cell, which is confirmed by the origin of the cell line originally maintained as cell line out of a brain metastatic, adenocarcinoma niche.


Subject(s)
Adenocarcinoma/ultrastructure , Brain Neoplasms/ultrastructure , Oxyphil Cells/ultrastructure , Prostatic Neoplasms/ultrastructure , Adenocarcinoma/chemistry , Adenocarcinoma/secondary , Brain Neoplasms/chemistry , Brain Neoplasms/secondary , Cell Line, Tumor , Cell Nucleus Shape , Cell Size , Glycogen/analysis , Humans , Male , Microscopy, Electron, Transmission , Mitochondria/ultrastructure , Oxyphil Cells/chemistry , Prostatic Neoplasms/chemistry , Ribonucleoproteins/analysis
18.
Ultrastruct Pathol ; 36(5): 294-311, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23025648

ABSTRACT

Androgen-independent, human prostate carcinoma cells (DU145) develop into solid, carcinomatous xenotransplants on the diaphragm of nu/nu mice. Tumors encompass at least two poorly differentiated cell types: a rapidly dividing, eosinophilic cell comprises the main cell population and a few, but large basophilic cells able to invade the peritoneal stroma, the muscular tissue, lymph vessels. Poor cell contacts, intracytoplasmic lumina, and signet cells are noted. Lysosomal activities are reflected by entoses and programmed cell deaths forming cribriform carcinomas. In large tumors, degraded cells may align with others to facilitate formation of blood supply routes. Malignant cells would spread via ascites and through lymphatics.


Subject(s)
Adenocarcinoma/ultrastructure , Carcinoma/ultrastructure , Prostatic Neoplasms/ultrastructure , Adenocarcinoma/blood supply , Animals , Apoptosis , Basophils/ultrastructure , Carcinoma/blood supply , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Entosis , Humans , Lymphatic Vessels/ultrastructure , Lysosomes/ultrastructure , Male , Mice , Mice, Nude , Microscopy, Electron, Transmission , Neoplasm Invasiveness , Neoplasm Transplantation , Phenotype , Prostatic Neoplasms/blood supply , Stromal Cells/ultrastructure , Transplantation, Heterologous
19.
BMC Cancer ; 11: 62, 2011 Feb 09.
Article in English | MEDLINE | ID: mdl-21303560

ABSTRACT

BACKGROUND: Prostate cancer is the single most prevalent cancer in US men whose gold standard of diagnosis is histologic assessment of biopsies. Manual assessment of stained tissue of all biopsies limits speed and accuracy in clinical practice and research of prostate cancer diagnosis. We sought to develop a fully-automated multimodal microscopy method to distinguish cancerous from non-cancerous tissue samples. METHODS: We recorded chemical data from an unstained tissue microarray (TMA) using Fourier transform infrared (FT-IR) spectroscopic imaging. Using pattern recognition, we identified epithelial cells without user input. We fused the cell type information with the corresponding stained images commonly used in clinical practice. Extracted morphological features, optimized by two-stage feature selection method using a minimum-redundancy-maximal-relevance (mRMR) criterion and sequential floating forward selection (SFFS), were applied to classify tissue samples as cancer or non-cancer. RESULTS: We achieved high accuracy (area under ROC curve (AUC) >0.97) in cross-validations on each of two data sets that were stained under different conditions. When the classifier was trained on one data set and tested on the other data set, an AUC value of ~0.95 was observed. In the absence of IR data, the performance of the same classification system dropped for both data sets and between data sets. CONCLUSIONS: We were able to achieve very effective fusion of the information from two different images that provide very different types of data with different characteristics. The method is entirely transparent to a user and does not involve any adjustment or decision-making based on spectral data. By combining the IR and optical data, we achieved high accurate classification.


Subject(s)
Carcinoma/pathology , Carcinoma/ultrastructure , Prostatic Neoplasms/pathology , Prostatic Neoplasms/ultrastructure , Area Under Curve , Automation, Laboratory , Carcinoma/metabolism , Histological Techniques/methods , Humans , Male , Microscopy/methods , Models, Biological , Models, Theoretical , Prostatic Neoplasms/metabolism , Sensitivity and Specificity , Spectroscopy, Fourier Transform Infrared , Tissue Array Analysis
20.
Int J Hyperthermia ; 27(8): 782-90, 2011.
Article in English | MEDLINE | ID: mdl-22098362

ABSTRACT

Minimally invasive thermal therapy using high-power diode lasers is an active area of clinical research. Gold nanoshells (AuNS) can be tuned to absorb light in the range used for laser ablation and may facilitate more conformal tumor heating and sparing of normal tissue via enhanced tumor specific heating. This concept was investigated in a xenograft model of prostate cancer (PC-3) using MR temperature imaging (MRTI) in a 1.5T scanner to characterize the spatiotemporal temperature distribution resulting from nanoparticle mediated heating. Tumors with and without intravenously injected AuNS were exposed to an external laser tuned to 808 nm for 180 sec at 4 W/cm(2) under real-time monitoring with proton resonance frequency shift based MRTI. Microscopy indicated that these nanoparticles (140-150 nm) accumulated passively in the tumor and remained close to the tumor microvasculature. MRTI measured a statistically significant (p < 0.001) increase in maximum temperature in the tumor cortex (mean = 21 ± 7°C) in +AuNS tumors versus control tumors. Analysis of the temperature maps helped demonstrate that the overall distribution of temperature within +AuNS tumors was demonstrably higher versus control, and resulted in damage visible on histopathology. This research demonstrates that passive uptake of intravenously injected AuNS in PC-3 xenografts converts the tumor vasculature into a potent heating source for nanoparticle mediated ablation at power levels which do not generate significant damage in normal tissue. When used in conjunction with MRTI, this has implications for development and validation of more conformal delivery of therapy for interstitial laser ablations.


Subject(s)
Laser Therapy , Magnetic Resonance Imaging/methods , Nanoshells , Prostatic Neoplasms/surgery , Animals , Cell Line, Tumor , Disease Models, Animal , Gold , Humans , Male , Mice , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Prostatic Neoplasms/ultrastructure , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL